Latest Docosahexaenoic acid Stories
Sancilio and Company, a leader in Advanced Lipid Technology improvements of omega-3 essential fatty acids, proudly announces the release of their newly redesigned Ocean Blue© Professional Omega-3 2100™ product line. Riviera Beach, Florida (PRWEB) May 15, 2013 The newly designed product line boasts a vibrant yellow color pallet and modern logo. In addition, SCI is introducing a new 30 count bottle to replace a 30 count blister box. All of the new features represent the strength...
A new study, published in the American Journal of Clinical Nutrition, demonstrated that mothers who took supplements during pregnancy containing omega-3 DHA experienced pregnancies of a healthier duration and gave birth to bigger babies. (PRWEB) May 13, 2013 Due to widespread dietary deficiencies of essential omega-3 fatty acids, doctors typically recommend that pregnant women add an Omega-3 supplement to their pre and postnatal care regimen. Recent research, conducted at the University...
WOODBRIDGE, ON, May 2, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that Dr. George Jackowski, Founder, Chairman and Chief Scientific Officer was awarded the Queen Elizabeth II Diamond Jubilee Medal for his significant contribution to the Canadian Biotech and Pharmaceutical Industries. Prime Minister Stephen...
WOODBRIDGE, ON, April 30, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that it will be presenting its top line results from its recently concluded clinical trial, at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2013 Scientific Sessions to be held in Lake Buena Vista,...
WOODBRIDGE, ON, April 29, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the fiscal year ended December 31, 2012. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated. Financial Review For the twelve months ended December 31, 2012 the...
Oregon State University researchers say omega-3 fatty acid DHA, such as found in Omega XL, has a powerful effect in preventing liver inflammation and fibrosis. Hollywood, FL (PRWEB) April 28, 2013 One of the first studies to directly compare the effects of omega-3 fatty acids DHA and EPA on liver disease was recently published online in the Journal of Nutrition. The study, supported by the USDA National Institute of Food and Agriculture, as well as the National Institutes of Health,...
DENVER, April 24, 2013 /PRNewswire-USNewswire/ -- Omega-3 polyunsaturated fatty acids (PUFAs), namely DHA and EPA found in fatty fish, are associated with lower risk of heart failure mortality in adults with chronic heart failure or who have experienced a heart attack. These fatty acids may also benefit young adults at risk of cardiovascular disease due to impaired fetal growth and low birth weight. These findings and more are summarized in the April 2013 PUFA Newsletter. A study of...
WOODBRIDGE, ON, April 9, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that VASCAZEN(®) met its primary endpoint in the REVEAL trial. Additionally, VASCAZEN(®) achieved statistical significance in various secondary endpoints in patients presenting with elevated triglycerides (>200mg/dL < 500mg/dL). The...
A new study published in the Canadian Journal of Psychiatry (Nov 2012) suggests omega-3 fatty acids, such as found in Omega XL by Great HealthWorks, can help new mothers with risk factors for postpartum depression Hollywood, FL (PRWEB) April 01, 2013 Postpartum depression is not only debilitating for women, but it can also have profound effects on their babies. Babies born to depressed mothers can be slower in reaching development milestones and are at higher risk for behavioral problems...
Michael Harper for redOrbit.com – Your Universe Online By now it’s nearly become common knowledge that fish oils carry plenty of health benefits for the body. Oils rich in DHA and EPA, for instance, have already been found to reduce inflammation, thereby preventing certain diseases. Researching these DHA and EPA-rich oils even further, Jennifer Fenton, Ph.D., M.P.H and researcher with the Department of Food Science and Human Nutrition at Michigan State University in East Lansing,...
